Cerner recently invested $266 million in the parent company of Lumeris, a value-based care management provider, as part of a 10-year agreement to combine the companies' technologies and services to aid hospitals in the transition to value-based contracts.
The EHR-giant now holds a minority stake in Lumeris, and the two will join forces to offer hospitals a new solution dubbed Maestro Advantage, an EHR-agnostic offering to help providers in value-based arrangements — including Medicare Advantage and provider-sponsored health plans — more easily control costs and improve outcomes.
Maestro Advantage works by combining data and insights with provider workflows to assess risk and recommend interventions that could lead to better outcomes for patients in value-based arrangements.
"Our collaboration with Cerner holds incredible promise at a time when it is urgent we fix our healthcare delivery system. Maestro Advantage creates a patient-centric healthcare delivery network. Prevention and wellness become the top priority rather than treatment and 'sick care,'" said Mike Long, chairman and CEO of Lumeris.
Under the agreement, Lumeris will adopt Cerner's HealtheIntent platform and merge its clinical methodology and advanced analytics.
"For decades, Cerner has focused on creating technology that improves how people receive and provide care," said Brent Shafer, chairman and CEO of Cerner. "By using data to reduce or eliminate unnecessary costs and ineffective transitions of care, providing doctors and their patients a more complete view of their medical history and a health plan that consistently receives high quality scores from CMS, this collaboration with Lumeris aligns well with our mission and illustrates the potential of Cerner technology to positively impact healthcare economics and outcomes in deeper, more impactful ways than before."